Myomo (MYO) Registration Filing summary

Company overview and business model

• Develops and markets wearable medical robotics, specifically the MyoPro myoelectric-controlled upper limb orthosis for individuals with neuromuscular disorders and upper limb paralysis.

• Products are custom-fabricated for each user and distributed primarily through direct billing to patients' insurance, as well as through O&P providers, the VA, and international distributors.

• Incorporated in Delaware in 2004 and headquartered in Boston, Massachusetts.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used for general corporate purposes, including sales and marketing, manufacturing, product development, clinical research, hiring, working capital, and capital expenditures.

• Management retains broad discretion over the allocation of proceeds.

Risk factors and disclosures

• Investment involves a high degree of risk, including risks detailed in recent SEC filings and incorporated by reference.

• Risks include reimbursement challenges, dependence on external financing, execution of business plans, regulatory approvals, competition, and intellectual property protection.

• Forward-looking statements are subject to significant uncertainties and actual results may differ materially.